← All trials
NCT06643780
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 9, 2024
- Primary completion
- Apr 30, 2027
- Completion date
- Oct 31, 2027
- First posted
- Oct 16, 2024
- Last posted
- Oct 16, 2024
- Enrollment
- 120
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- City University of Hong KongLead sponsor
- City University of Hong KongSponsor investigator
- Chinese University of Hong KongCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.